$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Microbiota refers to a collection of microorganisms (bacteria, viruses, archaea, bacteriophages, and fungi) living in a particular environment, and the microbiome refers to the collective genome of resident microorganisms. As bacteria are one of the most abundant microbes in humans and mice, this study is focused only on bacterial profiling. The human gut is colonized by trillions of bacteria and hundreds of bacterial strains1. The normal gut microbiota plays a vital role in maintaining a healthy state in the host by regulating functions (i.e., maintenance of an intact intestinal barrier, food metabolism, energy homeostasis, inhibition of colonization by pathogenic organisms, and regulation of immune responses)2,3,4,5. Compositional perturbations of the gut microbiota (gut dysbiosis) have been linked to a number of human diseases, including gastrointestinal disorders6, obesity7,8, stroke9, cancer10, diabetes8,11, rheumatoid arthritis12, allergies13, and central nervous system-related diseases such as multiple sclerosis (MS)14,15 and Alzheimer's disease (AD)8,16. Therefore, in recent years, there has been growing interest in tools for identifying bacterial composition at different body sites. A reliable method should have characteristics such as being high-throughput and easy-to-use, having the ability to classify bacterial microbiota with high resolution, and being low-cost.
Culture-based microbiological techniques are not sensitive enough to identify and characterize the complex gut microbiome due to the failure of several gut bacteria to grow in culture. The advent of the sequencing-based technology, especially 16S rRNA-based metagenomic sequencing, has overcome some of these challenges and transformed microbiome research17. Advanced 16S rRNA-based sequencing technology has helped in establishing a critical role for the gut microbiome in human health. The Human Microbiome Project, a National Institutes of Health initiative18, and the MetaHIT project (a European initiative)19 have both helped in establishing a basic framework for microbiome analysis. These initiatives helped kick-start multiple studies to determine the role of the gut microbiome in human health and disease.
A number of groups have shown gut dysbiosis in patients with inflammatory diseases12,14,15,20,21,22. Despite being widely used for taxonomic profiling due to the ability to multiplex and low costs, there are no uniform protocols for 16S rRNA-based taxonomic profiling. Another limitation is the low resolution of taxonomic assignment owing to smaller sequencing reads (150 bp or 250 bp) and use of only forward sequencing read (R1) due to low quality reverse sequencing reads (R2). However, advances in sequencing technology have helped to overcome some of these challenges, such as the ability to sequence longer reads using paired-end reads (e.g., Illumina MiSeq 2x300bp).
The present sequencing technology can sequence 600 bp good quality reads, which allows merging of R1 and R2 reads. These merged longer R1 and R2 reads allow better taxonomic assignments, especially with open-access R-based Divisive Amplicon Denoising Algorithm-2 (DADA2) platform. DADA2 utilizes amplicon sequence variant (ASV)-based assignments instead of operational taxonomic unit (OTU) assignments based on 97% similarity utilized by QIIME23. ASV matches result in an exact sequence match in the database within 1–2 nucleotides, which leads to assignment at genus and species levels. Thus, the combination of longer, good quality paired-end reads and better taxonomic assignment tools (such as DADA2) have transformed microbiome studies.
Provided here is a step-by-step guide for performing bacterial profiling using two-step amplification of the V3–V4 region of 16S rRNA and data analysis using DADA2, Phyloseq, and METAGENassist pipelines. For this study, human leukocyte antigen (HLA) class II transgenic mice are used, as certain HLA class II alleles are linked with a predisposition to autoimmune diseases such as MS20,24,25. However, the importance of HLA class II genes in regulating the composition of gut microbiota is unknown. It is hypothesized that the HLA class II molecule will influence gut microbial community by selecting for specific bacteria. Major histocompatibility complex (MHC) class II knockout mice (AE.KO) or mice expressing human HLA-DQ8 molecules (HLA-DQ8)24,25,26 were used in order to understand the importance of HLA class II molecules in shaping the gut microbial community. It is believed that this complete and simplified workflow with R-based data analysis will serve as an excellent tool for researchers interested in performing microbiome profiling studies.
The generation of mice lacking endogenous murine MHC class II genes (AE.KO) and AE-/-.HLA-DQA1*0103, DQB1*0302 (HLA-DQ8) transgenic mice with a C57BL/6J background has been described previously26. Fecal samples are collected from mice of both sexes (8–12 weeks of age). Mice were previously bred and maintained in the University of Iowa animal facility as per the NIH and institutional guidelines. Contamination control strategies such as weaning of the mice inside a laminar flow cabinet, changing of gloves between different strains of mice, and proper maintenance of mice are critical steps for profiling of gut microbiome.
Proper personal protective equipment (PPE) are highly recommended during the entire procedure. Appropriate negative controls should be included when performing DNA isolation, PCR1 and PCR2 amplification, and sequencing steps. Use of sterile, DNase-free, RNase-free, and pyrogen-free supplies is recommended. Designated pipettor for microbiome work and filtered pipette tips should be used throughout the protocol. Microbiota analysis consists of seven steps: 1) fecal sample collection and processing; 2) extraction of DNA; 3) 16S rRNA gene amplification; 4) DNA library construction using indexed PCR; 5) clean-up and quantification of indexed PCR (library); 6) MiSeq sequencing; and 7) data processing and sequence analysis. A schematic diagram of all protocol steps is shown in Figure 1.